• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拉考沙胺在成年癫痫患者中的上市后初步经验。

Initial post marketing experience with lacosamide in adult patients with epilepsy.

机构信息

Hofstra North Shore-LIJ School of Medicine, Cushing Neuroscience Institutes, Brain and Spine Specialists, North Shore-Long Island Jewish Health System, 270-05 76th Avenue, New Hyde Park, NY 11040, United States.

出版信息

Epilepsy Res. 2012 Feb;98(2-3):260-3. doi: 10.1016/j.eplepsyres.2011.09.010. Epub 2011 Oct 19.

DOI:10.1016/j.eplepsyres.2011.09.010
PMID:22015002
Abstract

The outcomes of adult epilepsy patients prescribed lacosamide for additional seizure control. Responders were defined as having at least a 50% decrease in seizure frequency Sixty-seven patients were evaluated. Forty-six out of 67 patients (69%) were responders. Twelve of 14 patients not taking sodium channel-acting AEDs were responders (86%) and 34/53 patients taking sodium channel-acting AEDs were responders (64%) (difference not significant).

摘要

接受拉科酰胺治疗以进一步控制癫痫发作的成年癫痫患者的结局。应答者定义为癫痫发作频率至少降低 50%。共评估了 67 例患者。67 例患者中有 46 例(69%)为应答者。未服用钠通道作用 AED 的 14 例患者中有 12 例(86%)为应答者,而服用钠通道作用 AED 的 53 例患者中有 34 例(64%)为应答者(差异无统计学意义)。

相似文献

1
Initial post marketing experience with lacosamide in adult patients with epilepsy.拉考沙胺在成年癫痫患者中的上市后初步经验。
Epilepsy Res. 2012 Feb;98(2-3):260-3. doi: 10.1016/j.eplepsyres.2011.09.010. Epub 2011 Oct 19.
2
Six months of postmarketing experience with adjunctive lacosamide in patients with pharmacoresistant focal epilepsy at a tertiary epilepsy center in Germany.德国一家三级癫痫中心有癫痫患者应用拉科酰胺辅助治疗耐药性局灶性癫痫的 6 个月上市后经验。
Epilepsy Behav. 2009 Nov;16(3):423-5. doi: 10.1016/j.yebeh.2009.07.043. Epub 2009 Sep 19.
3
Adjunctive lacosamide in clinical practice: sodium blockade with a difference?辅助左乙拉西坦的临床应用:钠通道阻滞,有何不同?
Epilepsy Behav. 2011 Nov;22(3):499-504. doi: 10.1016/j.yebeh.2011.07.035. Epub 2011 Sep 3.
4
Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.拉科酰胺作为难治性癫痫患儿辅助治疗的疗效。
J Child Neurol. 2014 Jan;29(1):23-7. doi: 10.1177/0883073812462887. Epub 2012 Nov 8.
5
Rational polytherapy with lacosamide in clinical practice: results of a Spanish cohort analysis RELACOVA.在临床实践中合理的拉考沙胺联合用药:RELACOVA 西班牙队列分析的结果。
Epilepsy Behav. 2012 Mar;23(3):298-304. doi: 10.1016/j.yebeh.2011.11.026. Epub 2012 Feb 26.
6
Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre.在一家三级中心使用拉考沙胺治疗癫痫的临床经验。
Acta Neurol Scand. 2013 Mar;127(3):149-53. doi: 10.1111/j.1600-0404.2012.01704.x. Epub 2012 Jul 31.
7
NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy.肿瘤研究:拉科酰胺在脑肿瘤相关性癫痫患者中的实际应用
Epilepsy Behav. 2016 Dec;65:25-32. doi: 10.1016/j.yebeh.2016.09.033. Epub 2016 Nov 16.
8
Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?拉考沙胺神经毒性与钠离子通道阻断抗癫痫药物同时使用相关:药效学相互作用?
Epilepsy Behav. 2011 Jan;20(1):20-3. doi: 10.1016/j.yebeh.2010.10.002. Epub 2010 Nov 5.
9
Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide.部分癫痫不同阶段发作的控制:LACO-EXP,拉考酰胺的西班牙回顾性研究。
Epilepsy Behav. 2013 Nov;29(2):349-56. doi: 10.1016/j.yebeh.2013.07.024. Epub 2013 Aug 30.
10
Experience with lacosamide in a series of children with drug-resistant focal epilepsy.拉考沙胺治疗耐药性局灶性癫痫儿童系列病例的经验。
Pediatr Neurol. 2011 Jun;44(6):414-9. doi: 10.1016/j.pediatrneurol.2010.12.003.

引用本文的文献

1
Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis.拉科酰胺在癫痫患者中的安全性和耐受性:一项系统评价和荟萃分析。
Front Pharmacol. 2021 Sep 20;12:694381. doi: 10.3389/fphar.2021.694381. eCollection 2021.
2
Lacosamide in the general population and in people with intellectual disability: Similar responses?拉科酰胺在普通人群和智障人群中的反应是否相似?
Seizure. 2020 Feb 19;76:161-166. doi: 10.1016/j.seizure.2020.02.013.
3
Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures.
左乙拉西坦辅助治疗小儿局灶性癫痫发作的疗效和耐受性。
Neurology. 2019 Sep 17;93(12):e1212-e1226. doi: 10.1212/WNL.0000000000008126. Epub 2019 Aug 28.
4
The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.拉科酰胺作为单药治疗及辅助治疗用于局灶性癫痫的疗效及其在癫痫持续状态中的应用:临床试验证据与经验
Ther Adv Neurol Disord. 2017 Feb;10(2):103-126. doi: 10.1177/1756285616675777. Epub 2016 Nov 29.
5
Early add-on lacosamide in a real-life setting: results of the REALLY study.现实环境中早期加用拉科酰胺:REALLY研究结果
Clin Drug Investig. 2015 Feb;35(2):121-31. doi: 10.1007/s40261-014-0255-5.